Literature DB >> 18622237

Y2 receptor gene variants reduce the risk of hypertension in obese children and adolescents.

Nicola Santoro1, Emanuele Miraglia Del Giudice, Anna Grandone, Pierluigi Marzuillo, Domenico Cozzolino, Giovanni Di Salvo, Giuseppe Pacileo, Raffaele Calabrò, Laura Perrone.   

Abstract

OBJECTIVE: To verify whether peptide YY (PYY) and its Y2 receptor (Y2R) gene variants can be associated with obesity or hypertension or both in a cohort of obese children and adolescents. PATIENTS AND METHODS: Two hundred and twenty-nine obese children (105 girls, mean z-score BMI 5.1 +/- 2.4; mean age 10.5 +/- 2.9 years) and 250 age and sex-matched lean controls (130 women, mean z-score BMI 0.5 +/- 1.1; mean age 10.3 +/- 2.8) were enrolled in the study. Height, weight, BMI, waist circumference and 24-h systolic and diastolic blood pressure were measured. Night-time, day-time and 24-h systolic and diastolic blood pressures were evaluated by 24 h ambulatory blood pressure measurement, and appropriate standard deviation scores according to sex, age and height were calculated. Molecular screening of the PYY and Y2R genes was performed.
RESULTS: No new mutations were found. We observed three previously described polymorphisms: G767C on PYY and T585C and T936C on Y2R. An association study was carried out in obese patients. No associations were found between the PYY genotypes and the studied phenotypes. The Y2R gene variants, T585C and T936C, which are in almost complete linkage disequilibrium, were found to be associated with night-time, day-time and 24-h systolic and diastolic blood pressures. In particular, subject homozygotes for the T allele showed lower systolic and diastolic blood pressure values compared with the other genotypes. Moreover, obese children homozygous for the T585 allele showed a lower risk of developing hypertension than patients carrying the CC and CT genotypes (chi 6.9; df = 1, P = 0.03; odds ratio = 0.5, 95% confidence interval: 0.27-0.88).
CONCLUSION: Our results suggest that Y2R gene variants are involved in blood pressure regulation in obese children and adolescents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622237     DOI: 10.1097/HJH.0b013e32830413ed

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects.

Authors:  Steven C Hunt; Sandra J Hasstedt; Yuanpei Xin; Brian K Dalley; Brett A Milash; Emanuel Yakobson; Richard E Gress; Lance E Davidson; Ted D Adams
Journal:  Obesity (Silver Spring)       Date:  2011-08-04       Impact factor: 5.002

2.  Peptide YY (PYY) gene polymorphisms in the 3'-untranslated and proximal promoter regions regulate cellular gene expression and PYY secretion and metabolic syndrome traits in vivo.

Authors:  Pei-An Betty Shih; Lei Wang; Stephane Chiron; Gen Wen; Caroline Nievergelt; Manjula Mahata; Srikrishna Khandrika; Fangwen Rao; Maple M Fung; Sushil K Mahata; Bruce A Hamilton; Daniel T O'Connor
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

3.  Subclinical myocardial dysfunction and cardiac autonomic dysregulation are closely associated in obese children and adolescents: the potential role of insulin resistance.

Authors:  Domenico Cozzolino; Anna Grandone; Antonio Cittadini; Giuseppe Palmiero; Giovanni Esposito; Annamaria De Bellis; Raffaello Furlan; Silverio Perrotta; Laura Perrone; Daniele Torella; Emanuele Miraglia Del Giudice
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

Review 4.  Genetic Programming of Hypertension.

Authors:  Sun-Young Ahn; Charu Gupta
Journal:  Front Pediatr       Date:  2018-01-22       Impact factor: 3.418

Review 5.  Development of hypertension in overweight adolescents: a review.

Authors:  Rebecca K Kelly; Costan G Magnussen; Matthew A Sabin; Michael Cheung; Markus Juonala
Journal:  Adolesc Health Med Ther       Date:  2015-10-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.